Target Group, Inc. (Canada) (CBDY)
0.0011
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Target Group Free Cash Flow (Quarterly) : -0.2294M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2294M |
| March 31, 2026 | -0.1338M |
| December 31, 2025 | -0.2508M |
| September 30, 2025 | -0.5537M |
| June 30, 2025 | 0.4573M |
| March 31, 2025 | -0.57M |
| December 31, 2024 | 0.7297M |
| September 30, 2024 | -0.3691M |
| June 30, 2024 | 0.9607M |
| March 31, 2024 | 0.7719M |
| December 31, 2023 | 0.273M |
| September 30, 2023 | -0.5705M |
| June 30, 2023 | -0.1221M |
| March 31, 2023 | -0.1868M |
| December 31, 2022 | 0.0554M |
| September 30, 2022 | 0.129M |
| June 30, 2022 | -1.347M |
| March 31, 2022 | 0.1477M |
| December 31, 2021 | 0.6119M |
| September 30, 2021 | -0.2362M |
| June 30, 2021 | -0.0076M |
| March 31, 2021 | -0.268M |
| December 31, 2020 | -0.2133M |
| September 30, 2020 | -0.3263M |
| June 30, 2020 | -0.0661M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.87M |
| December 31, 2019 | -0.2624M |
| September 30, 2019 | -1.895M |
| June 30, 2019 | -4.066M |
| March 31, 2019 | -3.110M |
| December 31, 2018 | -1.312M |
| September 30, 2018 | -1.081M |
| June 30, 2018 | -0.0554M |
| March 31, 2018 | -0.055M |
| December 31, 2017 | -0.0567M |
| September 30, 2017 | -0.0617M |
| June 30, 2017 | -0.0729M |
| March 31, 2017 | -0.0709M |
| December 31, 2016 | -0.1456M |
| September 30, 2016 | -0.1589M |
| June 30, 2016 | -0.1437M |
| March 31, 2016 | -0.1104M |
| December 31, 2015 | -0.0519M |
| September 30, 2015 | -0.0294M |
| June 30, 2015 | -0.0436M |
| March 31, 2015 | -0.0551M |
| December 31, 2014 | -0.0067M |
| September 30, 2014 | -0.0024M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.661M |
| InMed Pharmaceuticals, Inc. | -2.909M |
| XORTX Therapeutics, Inc. | -3.393M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.56M |